NASDAQ: BLUE - Bluebird Bio

Yield per half year: -65.33%
Sector: Healthcare

Bluebird Bio

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.72 -100% -3.98 -100%
P/S 31.05 33.75 -8%
P/BV 4.71 4.82 -2.27%
P/FCF -1.54 61 -102.52%
Ev/Ebitda -6.13 -22.17 -72.36%
Ev/S 34.73 22.56 53.97%
Ev/FCF -4.2 68.75 -106.1%
E/P -0.5645 0.0178 -3276.04%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-566.71 4.98 -11486.62% -5037.46 -88.75%
ROE -108.93 9.61 -1233.34%
ROA -34.23 0.3443 -10041.87%
ROIC -82.72 7.63 -1183.52%
ROS -718.42 -25.17 2754.26%
ROCE -46.7 15.35 -404.21%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.98 -3.68 -46.24% -1.28 +54.75%
Nеt Debt/Ebitda -0.6495 -3.44 -81.1%
Debt/Ratio 0.5335 0.1985 168.79%
Debt/Equity 1.66 1.66 -0.3891%
Debt/Net Income -1.56 10.32 -115.1%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-88.23 -56.89 55.09%
Growth impulse Ebitda in 5 years -73.72 -54.68 34.82%
Growth impulse Net Income in 5 years -65.75 -58.33 12.72%
Growth impulse FCF in 5 years -51.11 -49.48 3.29%
Growth impulse EPS in 5 years -80.61 -32.41 148.72%
IP Score
2.57/10

Similar companies

Illumina

Nektar Therapeutics

Amarin

Mylan

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription